Search
4 articles for “HPV vaccination”
-
HPV and Cardiovascular Risk: Unpacking a Novel Link Between Viral Infection and Heart Disease
Abstract: Human papillomavirus (HPV) is best known for its oncogenic potential, yet a growing body of evidence suggests that persistent HPV infection may also contribute to cardiovascular disease (CVD). In 2025, pooled analyses and conference reports galvanized attention by estimating that HPV‐positive individuals have ~40% higher risk of CVD and approximately double the risk of coronary artery disease (CAD) compared with HPV‐negative peers, even after adjustment for traditional risk factors. These …
Published in International Journal of Virus Studies · Vol. 2, Issue 2, 2025 · pp. 1–5 Read article
-
Challenges to Women's Adoption of the Human Papillomavirus Vaccine in India: An Updated Review
Abstract: The widespread availability of human papillomavirus (HPV) vaccines in some countries throughout the last ten years has demonstrated encouraging outcomes in reducing HPV infection and associated conditions including warts and precancerous lesions. We highlight vaccination coverage and efficacy in this study, which includes the most recent data on available HPV vaccinations. Furthermore, the topic of pan-gender immunisation and ongoing clinical trials is covered. Increasing vaccination coverage is now something that …
Published in International Journal of Vaccines · Vol. 2, Issue 2, 2025 · pp. 21–30 Read article
-
Effectiveness of structured teaching programme on knowledge regarding Prophylactic vaccination against cervical cancer among adolescent girls
Abstract: Background: Adolescent health encompasses the variety of methods used to prevent, identify, or treat the health and wellness of young people. Adolescent health also includes the sexual and reproductive health of children and young adults. Women of all ages are susceptible to HPV infection. The human papillomavirus is the cause of cervical cancer . The HPV vaccine is an important main preventive measure against cervical cancer . Thus, it is …
Published in International Journal of Vaccines · Vol. 2, Issue 2, 2025 Read article
-
CRISPR, Recombinant DNA, and LAMP-Based Platforms for Monkeypox: Emerging Tools for Diagnosis and Therapeutic Development
Abstract: Monkeypox, a zoonotic viral infection caused by the Monkeypox virus of the Orthopoxvirus genus, has recurred as a worldwide public health concern after recent outbreaks outside of its classical endemic areas in Central and West Africa. The resurgence has demanded a thorough reassessment of its epidemiology, mode of transmission, and clinical presentation. In light of these challenges, recombinant DNA technology (rDNA) has emerged as a candidate for developing vaccines, diagnostics, …
Published in International Journal of Virus Studies · Vol. 3, Issue 1, 2026 · pp. 7–28 Read article